Shoreline Biosciences

About:

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

Website: https://www.shorelinebio.com/

Top Investors: Cormorant Asset Management, BeiGene, Wedbush Securities, Biotechnology Value Fund, Kite Pharma

Description:

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients. Its proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity. The company was founded in 2020 and is headquartered in La Jolla, CA, USA.